MRP ₹210
(Inclusive of all Taxes)
₹31.5 Cashback (15%)
%2520JP_OneCard.png?tr=q-85,f-webp,w-50,dpr-1,c-at_max){kind=small}
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Manufacturer/Marketer :
Lloyd Healthcare Pvt Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Co-administration of Aliskiren with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking tizanidine with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Taking tizanidine with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Coadministration of enalapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking ramipril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking ramipril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking quinapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanPotassium iodide
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking Potassium Iodide with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Bylenta Trio 40 mg/10 mg/12.5 mg Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Taking Potassium Iodide with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Bylenta Trio 40 mg/10 mg/12.5 mg Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
TelmisartanPotassium citrate
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet:
Taking perindopril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet Substitute
Telvas-LNC 12.5 Tablet 10's
by Others
₹11.39per tabletTelicad-3d Tablet 10's
by AYUR
₹11.70per tabletCilnipres TC 12.5 mg Tablet 10's
by AYUR
₹12.15per tabletTelmikind Trio 12.5 Tablet 10's
by AYUR
₹12.33per tabletCilidin TCH Tablet 15's
by Others
₹12.60per tablet
Alcohol
Unsafe
Avoid consumption of alcohol with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet as it may increase the risk of low blood pressure and cause adverse effects such as dizziness, fainting, light-headedness, or headache.
Pregnancy
Unsafe
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet is not recommended for pregnant women as it may cause serious harm to the unborn baby. Please consult a doctor if you are pregnant.
Breast Feeding
Unsafe
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may be excreted in human milk and harm the baby. Therefore, avoid taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet if you are breastfeeding and consult a doctor.
Driving
Caution
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may cause dizziness or tiredness in some people. Therefore, avoid driving if you feel dizzy or tired after taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet .
Liver
Caution
Take Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required. Avoid taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet if you have severe liver disease.
Kidney
Caution
Take Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required. Avoid taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet if you have severe kidney disease.
Children
Unsafe
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet is not recommended for children below 18 years as safety and effectiveness have not been established.
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
